Researchers at the University of Southern California (USC) School of Medicine have discovered that e-cigarette flavors and device designs alter gene expression linked to cancer and heart disease. Published in the journal Frontiers in Oncology, the study warns that device mechanics and chemical additives pose immediate, visible cellular risks.
Because e-cigarettes are relatively new, chronic diseases like cancer may take decades to manifest. However, the research team analyzed changes in gene expression to capture early biological indicators of long-term health damage. They discovered that regular vapers exhibit altered activity across 3,124 genes in the human genome compared to non-vapers.
Surprisingly, the study found that the frequency of consumption plays a secondary role to the product’s design and flavor profile. Two-thirds of the observed genetic changes were directly linked to the specific flavors and device configurations used.
| Study Metric / Cohort | Details & Findings |
|---|---|
| Study Participants | 35 e-cigarette users, 24 smokers, and 24 non-users (all healthy young adults) |
| Total Altered Genes | 3,124 genes showed altered activity in regular vapers |
| Influence of Flavors & Devices | Responsible for 66.6% of observed genetic changes |
| Influence of Vaping Frequency | Responsible for 28.8% of observed genetic changes |
Users opting for fruit or mixed-flavor e-liquids, alongside advanced refillable devices known as “mods,” showed the most pronounced genetic alterations. Modern mods often deliver higher nicotine concentrations and contain potentially toxic additives designed to make the vapor smoother and more appealing, compounding the biological impact.
Using sophisticated bioinformatics, the researchers mapped these genetic changes to specific health conditions. Cancer was associated with the highest number of gene expression changes, followed by endocrine disorders, gastrointestinal diseases, and neurological conditions.
The scientists hope these findings will prompt the U.S. Food and Drug Administration (FDA) and other global regulatory bodies to enforce stricter standards on toxic additives and device specifications, particularly as the FDA finalizes its guidelines on flavored e-cigarettes.